Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 01, 2023

BUY
$191.51 - $216.16 $417,683 - $471,444
2,181 Added 14.04%
17,711 $3.76 Million
Q2 2023

Jul 31, 2023

SELL
$187.64 - $206.25 $10,507 - $11,550
-56 Reduced 0.36%
15,530 $2.99 Million
Q1 2023

May 02, 2023

BUY
$127.59 - $203.08 $28,962 - $46,099
227 Added 1.48%
15,586 $3.16 Million
Q4 2022

Feb 06, 2023

BUY
$117.37 - $139.17 $22,065 - $26,163
188 Added 1.24%
15,359 $1.97 Million
Q3 2022

Nov 02, 2022

BUY
$135.27 - $180.11 $127,424 - $169,663
942 Added 6.62%
15,171 $2.08 Million
Q2 2022

Aug 09, 2022

BUY
$108.81 - $179.33 $73,881 - $121,765
679 Added 5.01%
14,229 $2.52 Million
Q1 2022

Apr 29, 2022

BUY
$119.61 - $157.85 $144,130 - $190,209
1,205 Added 9.76%
13,550 $1.95 Million
Q4 2021

Feb 03, 2022

BUY
$142.57 - $190.86 $118,333 - $158,413
830 Added 7.21%
12,345 $1.91 Million
Q3 2021

Nov 05, 2021

BUY
$142.45 - $169.82 $175,355 - $209,048
1,231 Added 11.97%
11,515 $1.96 Million
Q2 2021

Aug 06, 2021

BUY
$135.08 - $161.1 $103,066 - $122,919
763 Added 8.01%
10,284 $1.62 Million
Q1 2021

May 03, 2021

BUY
$137.51 - $190.8 $158,824 - $220,374
1,155 Added 13.81%
9,521 $1.32 Million
Q4 2020

Feb 04, 2021

BUY
$164.63 - $211.93 $1.38 Million - $1.77 Million
8,366 New
8,366 $1.47 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.